Three Key Updates in HIV Treatment: EACS Guidelines
The latest EACS HIV treatment recommendations bring three important changes: a broader eligibility for dolutegravir/lamivudine, a revised approach to the historical M184V resistance mutation, and expanded consideration of long-acting injectable therapy for selected patients ...